Factors | Post-OP Adverse Outcome % | COR | (95% CI) | P-value | AOR | (95% CI) | P-value |
---|---|---|---|---|---|---|---|
Age (years) | |||||||
18–24 | 20.0 | 1 | 1 | ||||
25–49 | 59.1 | 5.77 | (0.55, 60.60) | 0.144 | 9.62 | (0.52, 177.36) | 0.128 |
50+ | 41.2 | 2.80 | (0.28, 27.79) | 0.379 | 5.95 | (0.34, 104.06) | 0.222 |
Sex | |||||||
Male | 55.0 | 1 | 1 | ||||
Female | 28.6 | 0.33 | (0.11, 1.01) | 0.053 | 0.26 | (0.05, 1.37) | 0.112 |
Delta albumin (%) | |||||||
< 14.77 | 33.3 | 1 | 1 | ||||
14.77 and above | 60.7 | 3.09 | (1.03, 9.31) | 0.45 | 6.68 | (1.59, 28.09) | 0.010 |
Surgical indication | |||||||
Emergency | 50.0 | 1 | 1 | ||||
Elective | 38.1 | 0.62 | (0.21, 1.81) | 0.377 | 1.28 | (0.27, 6.11) | 0.759 |
ASA | |||||||
1 | 47.6 | 1 | 1 | ||||
2 | 38.7 | 0.69 | (0.23, 2.13) | 0.524 | 0.44 | (0.10, 2.12) | 0.289 |
Length of surgery (min) | |||||||
0–120 | 38.9 | 1 | 1 | ||||
120 and above | 48.8 | 1.50 | (0.49, 4.60) | 0.478 | 1.73 | (0.35 8.45) | 0.500 |